FDA
-
-
-
-
-
-
-
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
-
-
-
-
-
-
-
NeuroPace reports 77% seizure reduction in epilepsy trial at 18 months
-
-
-
-
-
-
-
NeuroPace Inc (NPCE) PT Lowered to $13 at Wolfe Research
-
-
-
-
-
-
-
NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study
-
-
-
-
-
-
-
NeuroPace (NPCE) Announces Two Management Appointments
-
-
-
-
-
-
-
NeuroPace (NPCE) Announces RNS System Enhancements Designed to Streamline Care
-
-
-
-
-
-
-
NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery
-
326,432 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

